Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden

被引：0

作者：

Bellmunt, Joaquim

Powles, Thomas

Park, Se Hoon

Voog, Eric

Valderrama, Begona Perez

Gurney, Howard

Ullen, Anders

Loriot, Yohann

Sridhar, Srikala S.

Tsuchiya, Norihiko

Sternberg, Cora N.

Aragon-Ching, Jeanny B.

Petrylak, Daniel P.

Duran, Miguel A. Climent

Tyroller, Karin

Hoffman, Jason

Jacob, Natalia

Grivas, Petros

Gupta, Shilpa

机构：

[1] Beth Israel Deaconess Med Ctr, New York, NY USA

[2] Harvard Med Sch, Boston, MA USA

[3] Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, England

[4] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[5] Ctr Jean Bernard, Clin Victor Hugo, Le Mans, France

[6] Hosp Univ Virgen Rocio, Seville, Spain

[7] Macquarie Univ, Dept Clin Med, Westmead, NSW, Australia

[8] Karolinska Univ Hosp, Solna, Sweden

[9] Univ Paris Saclay, INSERMU981, Gustave Roussy, Villejuif, France

[10] Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON, Canada

[11] Yamagata Univ, Fac Med, Yamagata, Japan

[12] Englander Inst Precis Med, Meyer Canc Ctr, New York, NY USA

[13] Inova Schar Canc Inst, Fairfax, VA USA

[14] Yale Canc Ctr, New Haven, CT USA

[15] Inst Valenciano Oncol, Valencia, Spain

[16] EMD Serono, Billerica, MA USA

[17] Healthcare Business Merck KGaA, Darmstadt, Germany

[18] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA

[19] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4566

引用

页数：1